Watson Pharmaceuticals

Watson Pharmaceuticals spent $295,000 on lobbying (AP)

yahoo.com     Jun 19, 2008   2 related          

Wednesday June 18, 1:07 pm ET Watson Pharmaceuticals spent $295,000 lobbying government on drug issues in first quarter WASHINGTON (AP) -- Branded and generic drug maker Watson Pharmaceuticals Inc. spent more than $295,000...                    

comments

                   

Marcial: BioSante May Be Buyout Bait

businessweek.com     Jun 18, 2008   1 related          

The biotech's LibiGel, in clinical trials, could make it a player in treating female sexual dysfunction—and draw bids from Big Pharma BioSante Parmaceuticals—52-week stock price BioSante Parmaceuticals is going where Procter &...                    

comments

Depomed Announces Allowance of Additional U.S. Patent Covering Gabapentin GR(R)

redorbit.com     Jun 17, 2008   3 related          

Posted on: Tuesday, 17 June 2008, 06:00 CDT Depomed, Inc. (NASDAQ:DEPO) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for U.S. patent application number 10/280,309. Paul B....                    

comments

                   

Crocker Ventures Invests $3.3 Million in Merrimack Pharmaceuticals $60-Million F Round (Business...

yahoo.com     Jun 17, 2008   95 related          

SALT LAKE CITY----Crocker Ventures, a privately held Utah-based investment firm focused on early-stage biotechnology and other life science investments, today announced that it has deployed $3.3 million in a $60 million F round...                    

comments

                   

Crocker Ventures Invests $3.3 Million in Merrimack Pharmaceuticals $60-Million F Round

finanznachrichten.de     Jun 17, 2008   1 related          

Crocker Ventures, a privately held Utah-based investment firm focused on early-stage biotechnology and other life science investments, today announced that it has deployed $3.3 million in a $60 million F round for Merrimack...                    

comments

Watson Pharmaceuticals(GAAP) (WPI.GP) Weekly Earnings Information

pharmiweb.co.uk     Jun 15, 2008   6 related          

Released : Sunday, June 15, 2008 5:14 AM Company: Watson Pharmaceuticals(GAAP) (WPI.GP) Actual EPS for FY End (12/2007): 1.27 Current FY High EPS Estimate: 1.86 Current FY Low EPS Estimate: 1.86 Current FY Consensus Estimate:...                    

comments

                   

FDA generic drug reviews delayed, report finds (Reuters)

yahoo.com     Jun 14, 2008   11 related          

Reuters - The U.S. Food and Drug Administration failed to review on time nearly half the applications from generic drug makers seeking approval to sell cheaper versions of brand-name pharmaceuticals, according to a government...                    

comments

                   

Sector Snap: Generic Drug Developers

ibtimes.com     Jun 11, 2008   17 related          

Generic drug developers will continue taking advantage of global demand for lower-priced drugs, with industry giant Teva Pharmaceutical Industries Ltd. poised to maintain its lead position, according to a Goldman Sachs analyst.                    

comments

Ranbaxy Labs Fetches $4.6 Billion (at TheStreet.com)

yahoo.com     Jun 11, 2008   387 related          

Japanese drugmaker Daiichi Sankyo has inked a $4.6 billion deal to acquire India-based generic-drug maker Ranbaxy Laboratories. Daiichi Sankyo will pay 737 rupees per share, for a total price between $3.4 billion to $4.6...                    

comments

                   

Research and Markets: Analysis of Watson Pharmaceuticals Report Out Now

pharmiweb.co.uk     Jun 11, 2008   32 related          

Wednesday June 11, 7:05 am ET DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Analysis of Watson Pharmaceuticals" companyprofile to their offering. We present Analysis of Watson...                    

comments